Folate, Vitamin B12, and Mental Health

Low folate status has long been associated with depression. In a study published in Clinical Nutrition (2006;25(1):60–67), 224 newly admitted psychiatric patients were found to have significantly lower serum folate levels than healthy controls. Low folate correlated with depression severity.

The same study did not find a consistent correlation between serum vitamin B12 (cobalamin) levels and depression—but this may reflect limitations of serum B12 testing rather than a lack of biological relevance.

Why Serum B12 Is an Incomplete Test

Serum cobalamin alone is not a reliable marker of vitamin B12 status. A large review published in the American Journal of Hematology (1990;34:99–107), involving 419 cases of confirmed B12 deficiency, found:

  • 95% of B12-deficient patients had elevated methylmalonic acid (MMA) and/or homocysteine

  • Only 69% had low serum cobalamin

  • Some patients with clear neurologic or hematologic B12 deficiency had “normal” serum B12 levels

The authors concluded that MMA and homocysteine are far more sensitive markers of B12 deficiency than serum cobalamin alone. It should be noted that homocysteine may also be elevated in folate deficiency, and will not normalize with B12 alone.

Aging, Cognition, and Hidden Deficiency

Vitamin B12 levels tend to decline with age (Archives of Family Medicine, 1994;3:918–922). Several studies suggest that cognitive and psychiatric symptoms in older adults may reflect unrecognized B12 or folate deficiency.

In a study of 296 elderly patients with mental illness (European Journal of Clinical Investigation, 1994;24:600–606):

  • Over 7% had normal serum B12 but elevated homocysteine

  • B12 injections reduced homocysteine

  • Adding folic acid further improved results in those with low folate

Cognitive Function and Timing Matters

A small pilot study published in the Journal of the American Geriatrics Society (1992;40(2):168–172) evaluated 22 patients with low B12 and cognitive impairment treated with B12 injections over six months. Of the 18 patients who completed the study, 11 showed cognitive improvement, measured by the Mattis Dementia Rating Scale.

Importantly, patients with shorter symptom duration improved the most, suggesting a limited window of opportunity for reversal once neurologic damage progresses.

Why This Still Matters

Folate and vitamin B12 deficiencies are common, underdiagnosed, and clinically relevant, particularly in psychiatric and elderly populations. Reliance on serum B12 alone can miss a substantial number of deficient patients. When mood, cognition, or neurologic symptoms are present, functional markers such as methylmalonic acid and homocysteine provide a more accurate assessment and may identify reversible contributors to decline.